MAGNESIUM SULPHATE VERSUS PHENYTOIN FOR ECLAMPSIA: ONE YEAR PROSPECTIVE STUDY

Authors

  • Mona Sharma B. P. Koirala Institute of Health Sciences, Dharan
  • R Koirala B. P. Koirala Institute of Health Sciences, Dharan
  • U Sharma B. P. Koirala Institute of Health Sciences, Dharan
  • P Singh B. P. Koirala Institute of Health Sciences, Dharan
  • S Gupta B. P. Koirala Institute of Health Sciences, Dharan

DOI:

https://doi.org/10.31729/jnma.734

Abstract

Aim: Eclampsia is one of the important preventable causes of maternal mortality.
This study aims to review the clinical profile of eclamptic women and compare the
maternal mortality, recurrence of convulsions, other morbidities including the neonatal
outcome with Magnesium Sulphate versus Phenytoin used for its management.
Material and Methods: Prospective study was carried out in all the eclamptic patient
admitted in Gynae ward from April 2000 - April 2001 (Baisak 2057 to Chaitra 2057).
Results: There were total of 30 patients.Most of the them (53.3%) were of the 15-20
years of age group and three fourth (73%) were primigravidas. More than half (56%)
were unbooked and one fourth were nonimmunised and illiterate .Blood pressure had
never been measured in 63% of the patient . In the Phenytoin Group 68.75% had
recurrences of fits where as in the Magnesium Sulphate Group only 21.43 % had
reccurence. In the Magnesium Sulphate group, 50% delivered normally whereas 42.5%
needed caesarean section in the Phenytoin group Only 6.2% delivered normally and
in 37.5 % forceps had to be applied. There were 37.50% admission to Neonatal
Intensive Unit (NICU) for various complications in Phenytoin group whereas there
were only 14.2% NICU admission in Magnesium Sulphate group. There were two
cases of neonatal deaths out of 16 neonates in the Phenytoin group whereas only one
out of 14 cases in Magnesium Sulphate group. There was only one maternal death in
these thirty patients and it belonged to the Phenytoin group.
Conclusion: As proved in many other studies this study also showed that Magnesium
Sulphate was superior to Phenytoin in terms of recurrence of fits, maternal and neonatal
outcome. In our country where many deaths still occur due to Eclampsia the valuable
role of magnesium Sulphate should not be ignored and health personnels should be
trained for its frequently than it is practiced to-day.

Key Words: Eclampsia, Preeclampsia, Magnesium Sulphate, Phenytion.

Downloads

Published

2003-01-01

How to Cite

Sharma, M., Koirala, R., Sharma, U., Singh, P., & Gupta, S. (2003). MAGNESIUM SULPHATE VERSUS PHENYTOIN FOR ECLAMPSIA: ONE YEAR PROSPECTIVE STUDY. Journal of Nepal Medical Association, 41(141), 247–52. https://doi.org/10.31729/jnma.734

Issue

Section

Original Article

Most read articles by the same author(s)